MIR22HG regulates miR-486/PTEN axis in bladder cancer to promote cell proliferation

Qisheng Tang1, Xue Jiang2, Shanjin Ma1

  • 1Department of Urology, Tangdu Hospital, Air Force Medical University, Xi'an City, Shaanxi Province 710038, China.

Bioscience Reports
|June 6, 2020
PubMed

Insights

MIR22HG suppresses bladder cancer (BC) by regulating the miR-486/PTEN axis. Down-regulation of MIR22HG promotes BC cell proliferation, while its overexpression inhibits it.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • The tumor-suppressive function of MIR22HG is recognized across various cancers.
  • MIR22HG's role in bladder cancer (BC) pathogenesis requires further elucidation.

Purpose of the Study:

  • To investigate the role of MIR22HG in bladder cancer.
  • To explore the molecular mechanism of MIR22HG in regulating BC cell proliferation.

Main Methods:

  • Analysis of The Cancer Genome Atlas (TCGA) dataset for MIR22HG expression in BC.
  • Bioinformatics analysis and dual-luciferase reporter assays to confirm MIR22HG-miR-486 interaction.
  • Cell proliferation assays to assess the functional impact of MIR22HG, PTEN, and miR-486.

Main Results:

  • MIR22HG was found to be down-regulated in bladder cancer.
  • MIR22HG directly interacts with miR-486 but does not affect its expression.
  • MIR22HG overexpression up-regulates PTEN, inhibiting BC cell proliferation, an effect reversed by miR-486.

Conclusions:

  • MIR22HG acts as a tumor suppressor in bladder cancer.
  • MIR22HG regulates BC cell proliferation through the miR-486/PTEN axis.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.6K